Improving Molecule Generation and Drug Discovery with a Knowledge-enhanced Generative Model
Recent advancements in generative models have established state-of-the-art benchmarks in the generation of molecules and novel drug candidates. Despite these successes, a significant gap persists between generative models and the utilization of extensive biomedical knowledge, often systematized within knowledge graphs, whose potential to inform and enhance generative processes has not been realized. In this paper, we present a novel approach that bridges this divide by developing a framework for knowledge-enhanced generative models called KARL. We develop a scalable methodology to extend the functionality of knowledge graphs while preserving semantic integrity, and incorporate this contextual information into a generative framework to guide a diffusion-based model. The integration of knowledge graph embeddings with our generative model furnishes a robust mechanism for producing novel drug candidates possessing specific characteristics while ensuring validity and synthesizability. KARL outperforms state-of-the-art generative models on both unconditional and targeted generation tasks.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoveryKnowledge Graph EmbeddingsKnowledge GraphsSimilar Papers 제목 키워드 기반
Augmenting generative models with biomedical knowledge graphs improves targeted drug discovery
Recent breakthroughs in generative modeling have demonstrated remarkable capabilities in molecular generation, yet the integration of comprehensive biomedical knowledge into these models has remained an untapped frontier…
Knowledge GraphsDrug DiscoveryLeveraging Partial SMILES Validation Scheme for Enhanced Drug Design in Reinforcement Learning Frameworks
SMILES-based molecule generation has emerged as a powerful approach in drug discovery. Deep reinforcement learning (RL) using large language model (LLM) has been incorporated into the molecule generation process to achie…
Deep Reinforcement LearningDrug DesignDrug DiscoveryLarge Language Model+1DrugGen enhances drug discovery with large language models and reinforcement learning
Traditional drug design faces significant challenges due to inherent chemical and biological complexities, often resulting in high failure rates in clinical trials. Deep learning advancements, particularly generative mod…
Drug DesignDrug DiscoveryvalidDrugGen: Advancing Drug Discovery with Large Language Models and Reinforcement Learning Feedback
Traditional drug design faces significant challenges due to inherent chemical and biological complexities, often resulting in high failure rates in clinical trials. Deep learning advancements, particularly generative mod…
Drug DesignDrug DiscoveryRegressor-free Molecule Generation to Support Drug Response Prediction
Drug response prediction (DRP) is a crucial phase in drug discovery, and the most important metric for its evaluation is the IC50 score. DRP results are heavily dependent on the quality of the generated molecules. Existi…
Common Sense ReasoningDrug DiscoveryDrug Response PredictionPrediction+1